Cipla, Dr Reddy’s Laboratories, Emcure Pharmaceuticals, Sun Pharmaceutical Industries and Torrent Pharmaceuticals have announced today that these five companies will collaborate for the clinical trial of the investigational oral anti-viral drug Molnupiravir for the treatment of mild COVID-19 in an outpatient setting in India.

Power Mech Projects Limited has made a new 52-week high of Rs 767.30 today after it won a mine development & operation (MOO) project from Central Coalfields Limited (CCL), a subsidiary of Coal India Limited, aggregating to Rs 9,294 crore over the contract period. 

Vaishali Pharma Limited has received orders from Nicaragua and a preliminary order from Madagascar for the supply of its registered products including various antibiotics and other generic medicines such as painkillers, etc.

HFCL Limited in collaboration with Telecom Infra Project (TIP) has announced setting up their second PM-WANI powered connectivity for Baidebattu village in Karnataka. 

Dabur Limited has informed the bourses that today, it has commenced the construction of its largest, most modern, and environment-friendly manufacturing facility in Indore (Madhya Pradesh).

Subex Limited has announced a strategic tie-up with Spire Solutions, which is a leading value-added distributor (VAD) of Middle East & Africa to address the steep rise in cyberattacks and associated cyber risks in the region.

Vaishali Pharma Limited has received an order in excess of 1,00,000 US dollars from Russia for the supply of its registered veterinary product. 

Cadila Healthcare Limited as a joint venture partner has signed an agreement to extend the tenure of the joint venture agreement (JVA) with Bayer (Southeast Asia) PTE Limited, one of the companies of Bayer Group, for a period of three years. 

Datamatics Global Services Limited has made a new 52-week high of Rs 179.70 today by surging 15 per cent during the early morning session. On a YTD basis, the stock has given a return of approximately 55 per cent to the investors.

Lupin Limited has received approval for its Sevelamer Hydrochloride tablets, 400 mg & 800 mg from United States Food & Drug Administration (USFDA) to market a generic equivalent of Renagel tablets, 400 mg & 800 mg, of Genzyme Corporation. The product will be manufactured at Lupin’s facility in Nagpur (Maharashtra).